Olink Explorer >5400
- Response deadline
- Jul 25, 2026 Closed
- Date posted
- Jul 15, 2026
- Source
- Open notice
Description
Requirements: 2.0 BACKGROUND Our lab studies the role of inflammation/innate resistance and commensal microbiota in carcinogenesis, cancer progression and therapy of cancer. The following product features/characteristics are required for this requirement: Protein Coverage - Measures ~5,400+ human proteins simultaneously in a single workflow. Technology - Uses Proximity Extension Assay (PEA) with dual antibody recognition coupled to DNA barcoding and next-generation sequencing (NGS) readout. Sample input – requires only 2 ul of plasma, serum, and other sample types Specificity - Reported 99.5% specificity with negligible cross-reactivity due to dual-recognition antibody design. Dynamic Range - Approximately 10 orders of magnitude (fg/mL to mg/mL), enabling detection of both low- and high-abundance proteins. Key strengths Very broad proteome coverage while maintaining antibody-based specificity. Excellent sensitivity for low-abundance circulating proteins (especially cytokines and signaling proteins). Extremely low sample-volume requirement. Highly standardized platform, making it attractive for epidemiology and multi-omics studies.
Classifications
Documents (1)
- Requirement 7.docx.docx17 KBNot yet available
Contacts
Similar contracts
- Effluent Wastewater Testing - Saginaw VAMCMichigan
- Chemical Nutrient Analysis Service for Combat Feeding Division (CFD)MassachusettsDue Oct 29, 2026
- Precision cleaning and calibration of select mission-critical hardwareDue Oct 20, 2026
- CJD National Pollutant Discharge Elimination System (NPDES) Laboratory Services - Base plus 4 Option YearsWashingtonDue Oct 21, 2026
- Flowmeter, Calibration, and Signal Conditioners Needed for Panel Modification for EsrDue Oct 22, 2026
- Granite Surface Plate Calibration and lappingIllinoisDue Nov 9, 2026